Comparing the Stanford Letter Project Form to Traditional Advance Directives (SLP)

April 4, 2024 updated by: VJ Periyakoil, Stanford University
Our goal is to compare two types of advance directives forms available in English and Spanish to determine which is more easy to use for patients.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Step1: Any adult participant who is interested in completing advance directives and able to read and write in English and or Spanish will be eligible to participate in the study

Step 2:

Online Stanford consent form will be presented before the participants. Only after they read the consent and click on the participation link will they be able to enter the study.Those who are willing to participate will be randomly assigned to either the letter or traditional advance directives in Spanish and study measures. They will also answer questions as to how much they liked and understood the documents.

Step 4: The investigators will collect data until the investigators reach an n=1000

Step 5: The investigators will analyze the results and submit for publication.

In this protocol, we are assessing whether patients prefer the traditional advance directives or the letter directive. As it is just an questionnaire based study, there no risk for patients.

Study Type

Interventional

Enrollment (Estimated)

1000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Stanford, California, United States, 94305
        • Recruiting
        • Stanford School of Medicine
        • Contact:
          • VJ Periyakoil, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Over 18 years of age

Exclusion Criteria:

  • Under 18

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Participants in the intervention arm complete the Stanford letter advance directive
Participants will be randomly assigned to one of two advance directives and we will assess which they prefer. This is not a human health intervention
Other Names:
  • Advance Directive
Active Comparator: Control
Participants in the control arm complete the California state traditional advance directive
Participants will be randomly assigned to one of two advance directives and we will assess which they prefer. This is not a human health intervention
Other Names:
  • Advance Directive

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ease of use of Questionnaire. more patient-centered and family oriented
Time Frame: 1year
It was easy to read and understand the form of advance directive .◦This is a feasibility trail. On completion of the advance directive they were assigned ( letter directive or traditional directive, we are asking questions to participants about whether the directive was clear and easy to understand).
1year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ease of use to describe how decisions are made
Time Frame: 1year
Advance form helped me to describe how decisions are made
1year
Ease of use about the type of treatment and care.
Time Frame: 1year
Advance form stimulated my own thinking about the type of treatment and care they wish to receive in my last days of life.
1year
Ease of use about letting my doctors about my wishes.
Time Frame: 1 year
This form can help my doctors understand what treatments would like to receive and what not wish to receive in my last days of life ( resuscitation , respirators , artificial feeding , renal dialysis).
1 year
Ease of use if I cannot make decisions for myself then the form says it.
Time Frame: 1 year
In the future, if I can not make decisions for myself, this form will help my family / friends understand exactly what treatments ( resuscitation , respirators , artificial feeding , renal dialysis) would like to receive and what treatments do not wish to receive so they can make decisions medical for me.
1 year
Ease of use about my future preferences.
Time Frame: 1 year
There were issues with my future preferences that were not covered in the form of advance directive .
1 year
Ease of use of the form itself.
Time Frame: 1 year
I feel comfortable using form for advance care planning .
1 year
Ease of use and the comments participants may have.
Time Frame: 1 year
Any comments participants may have about the form of advance directive ? What can investigators do for patients and their families understand it better?
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: VJ Periyakoil, MD, Stanford University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

June 7, 2016

First Submitted That Met QC Criteria

June 9, 2016

First Posted (Estimated)

June 15, 2016

Study Record Updates

Last Update Posted (Actual)

April 8, 2024

Last Update Submitted That Met QC Criteria

April 4, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Palliative Care

Clinical Trials on Randomized clinical study

Subscribe